Dartmouth funded as an NSF Innovation Corps Site
April 18, 2016
The National Science Foundation grant will strengthen the bridge between technological innovation and Dartmouth's suite of entrepreneurial services offered through OETT and DEN.
Martin de Bustamante ’08 Th’09 sees success in business
April 4, 2016 | The Dartmouth
Monica Martin de Bustamante '08 Th'09 majored in engineering sciences and Romance languages all while playing both soccer and rugby and then founded her own biopharmaceutical consulting firm.
Remote-controlled tackling dummy puts on a show at college football practice
March 29, 2016 | mLive
The Mobile Virtual Player (MVP), a motorized tackling dummy created at Dartmouth, was put through its paces by Rogers Athletic Company.
Professor Geoffrey Parker is co-author of "Platform Revolution" — out on the shelves today.
Pipelines, Platforms, and the New Rules of Strategy
March 23, 2016 | Harvard Business Review
Professor Geoffrey Parker and his co-authors explain a phenomenon called “network effects” which is central to platform strategy and is transforming competition.
Mutant Yeast Are Cranking Out Pharma’s Next Superdrug
March 10, 2016 | WIRED
Professor Gerngross's Adimab is using yeast to cure practically any disease for which a treatment is so ambitious doctors only dare to dream about it.
Adimab issues a challenge: Use new tech to build a rapid-response R&D platform for infectious diseases
February 18, 2016 | FierceBiotech
Adimab CEO Tillman Gerngross wants to challenge the way governments handle the R&D response to a viral outbreak.
In April, the Center for Imaging Medicine will serve as Platinum Sponsor of the Optical Society Biomedical Optics Congress during the Society’s historic 100-year celebration.
Center Receives $6.2m to Develop Rehabilitation and Assistive Technologies
February 4, 2016 | Center for the Translation of Rehabilitation Engineering Advances and Technology
The Center for the Translation of Rehabilitation Engineering Advances and Technology (TREAT) was recently awarded five years of additional funding from the National Institutes of Health (NIH).
Dementia Discovery Fund Chooses Alector for First Investment
January 7, 2016 | The Wall Street Journal
Alector, founded by Professor Tillman Gerngross, is developing drugs to address what its founders believe could be the root cause of dementia.